Posts tagged “N.C. Biotech Center”

1:00 p.m. Monday

Jim Shamp: Is science comedian an oxymoron? No, it's Tim Lee, Ph.D., and he's definitely no moron

You don't have to be an ag whiz to harvest a heap of fun from the N.C. Biotechnology Center's get-together on Wednesday with Tim Xtreme Lee, who has a Ph.D. in biology and the equivalent in comedy.

Dr. Tim Lee Dr. Tim Lee

6:20 a.m. Monday

Input: WTW wants to hear from you - send us news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

June 23

Chapel Hill drug firm talks FDA approval path for migraine drug

Migraine ​Achelios Therapeutics of Chapel Hill has completed a meeting with the U.S. Food and Drug Administration about a path to approval for its leading drug candidate to treat acute and chronic migraine

Updated June 21

World-leading Seqirus flu vax factory in Holly Springs hits another milestone

The billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit yet another milestone.

Seqirus factory in Holly Springs Seqirus factory in Holly Springs

June 21

Eshelman, Hatteras backed Innocrin lands regulatory boost in Europe

​Durham-based Innocrin Pharmaceuticals, a clinical-stage company focused on developing new cancer treatments, has received a regulatory boost for its work in Europe.

Innocrin Innocrin

June 20

Special Forces seek private industry's help to meet special needs

The U.S. Special Operations Forces, which include Navy Seals, Army Rangers, and Air Force Special Tactics, have 9,500 people deployed in 90 countries. So they have special needs when it comes to acquisitions from private-sector partners.

U.S. Special Forces U.S. Special Forces

June 19

FDA approves generic commercial active pharmaceutical ingredient from Cary drug maker

drugs CiVentiChem has received its first U.S. Food and Drug Administration approval for a generic commercial active pharmaceutical ingredient (API) manufactured at its Cary headquarters.

Updated June 19

World Economic Forum names Triangle's Humacyte a top 'Technology Pioneer'

​Humacyte, a Morrisville-based regenerative medicine company, has been selected as one of the World Economic Forum's 30 "Technology Pioneers" for 2017.

Sample of a Humacyl vessel Sample of a Humacyl vessel

Updated June 19

Premium Lock Startup Grind Triangle hosting entrepreneur conference

Startup Grind With a lineup of speakers that includes some of the top tech stars of the Triangle, Startup Grind is planning a one-day conference for entrepreneurs this October.

June 19

WTW wants to hear from you - send us news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated June 16

US military seeks partners to help warfighters, families

Vice Admiral Raquel Bono One thing was clear, from the opening keynote to the final session, after a unique gathering of North Carolina business and Pentagon procurement leaders: The military is actively seeking private-sector partners to support the health and healing of U.S. warfighters and their families.

Updated June 12

Premium Lock Experimental BioCryst drug a Zika killer?

BioCryst Pharmaceuticals Durham-based BioCryst Pharmaceuticals might have a Zika bazooka on its hands. So says Jim Shamp at the NC Biotech Center.

June 12

Speak your mind: WTW wants to hear from you - send us news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated June 9

Merz Neurosciences reports positive results for neurotoxin drug

Merz Pharma Merz Neurosciences, a division of Raleigh-based Merz North America, has reported positive results from a Phase 3 clinical trial of its drug Xeomin for the treatment of adult sialorrhea, or unwanted drooling, due to Parkinson's disease and other neurologic disorders.

June 8

Bioventus lands major surgical orthobiologics deal

A Bioventus product: Purebone  In a big win for its surgical business, Durham-based Bioventus says all of its surgical orthobiologics products are now available through Premier Inc., a large group purchasing organization consisting of 3,750 U.S. hospitals and more than 130,000 other healthcare providers.

June 7

Premium Lock Report: Health sciences contribute $3.7B to NC economy

Biotech & Life Science As the General Assembly mulls possible cuts to the N.C. Biotechnology Center's budget, a new report from RTI International finds that global health-related work contributed $3.7 billion to the state's economy. Plus: Read the report's abstract.

Updated June 7

Jim Roberts: Startups swarm life science forum for investor insights

Jim Roberts I have always heard how hard it is for Life Sciences startups to raise early stage seed capital, so to hear insights from six investors made for a great event at the N.C. Biotech Center this week. Here's a look at some highlights and keep takeaways.

June 6

Joe Magno: Life sciences forum on VC draws standing-room-only crowd

Speakers covered topics ranging from investment criteria to typical investment commitment and also covered syndication and partnering with other investors from private individuals to direct corporate investment partnerships.

Panel talks biotech VC funding Panel talks biotech VC funding

June 5

Give us a shout: WTW wants to hear from you - send us news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith